The purpose of the Biometrics Shared Resource is to provide statistical support for CINJ members in the areas of population, clinical, and laboratory research. The Biometrics Shared Resource delineated the following goals for the next grant period: 1. To provide statistical consultation to CINJ members in the design of research projects. 2. To provide statistical consultation to the Protocol Review and Monitoring Committee. 3. To provide statistical monitoring for ongoing research. 4. To provide statistical consultation for the computation and analysis of data derived from research projects. 5. To assist in the production of routine and customized data reports as needed for presentations and/or publications. 6. To assist in development of annual reports and other statistically valid data displays for regulatory agencies and institutional monitoring committees. These goals will be accomplished through the leadership of a newly recruited shared resource manager, Dr. Weichung Joe Shih, who was a senior biostatistician at Merck, Inc., with over 16 years of experience. He will be assisted by two additional biostatisticians from Rutgers University and from the Robert Wood Johnson Medical School. The use of the Biometrics Shared Resource has grown in parallel with the growth of CINJ as a whole. With the creation of programs in populations science and the overall expansion of the research base, this shared resource will be of critical importance to the center during the net grant period.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA072720-04
Application #
6403477
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2000-04-06
Project End
2005-02-28
Budget Start
Budget End
Support Year
4
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Type
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Herman, Joseph M; Jabbour, Salma K; Lin, Steven H et al. (2018) Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation. Pancreas 47:208-212
Patrizii, Michele; Bartucci, Monica; Pine, Sharon R et al. (2018) Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy. Front Oncol 8:23
Zloza, Andrew (2018) Viruses, bacteria, and parasites - oh my! a resurgence of interest in microbial-based therapy for cancer. J Immunother Cancer 6:3
CeliĆ -Terrassa, Toni; Bastian, Caleb; Liu, Daniel et al. (2018) Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nat Commun 9:5005
George, Blessy; Joy, Melanie S; Aleksunes, Lauren M (2018) Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood) 243:272-282
Paratala, Bhavna S; Chung, Jon H; Williams, Casey B et al. (2018) RET rearrangements are actionable alterations in breast cancer. Nat Commun 9:4821
Jian-Yu E; Graber, Judith M; Lu, Shou-En et al. (2018) Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis. Curr Med Chem 25:2595-2607
Moloughney, Joseph G; Vega-Cotto, Nicole M; Liu, Sharon et al. (2018) mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation. J Biol Chem 293:16464-16478
Zhu, Sining; Jin, Juan; Gokhale, Samantha et al. (2018) Genetic Alterations of TRAF Proteins in Human Cancers. Front Immunol 9:2111
Perekatt, Ansu O; Shah, Pooja P; Cheung, Shannon et al. (2018) SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium. Cancer Res 78:4878-4890

Showing the most recent 10 out of 775 publications